Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) Equity Average (2020 - 2025)

Historic Equity Average for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $383.0 million.

  • PROCEPT BioRobotics' Equity Average rose 5539.08% to $383.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $383.0 million, marking a year-over-year increase of 5539.08%. This contributed to the annual value of $341.5 million for FY2024, which is 4293.38% up from last year.
  • As of Q3 2025, PROCEPT BioRobotics' Equity Average stood at $383.0 million, which was up 5539.08% from $387.5 million recorded in Q2 2025.
  • PROCEPT BioRobotics' 5-year Equity Average high stood at $395.7 million for Q1 2025, and its period low was -$200.1 million during Q2 2021.
  • Its 5-year average for Equity Average is $210.6 million, with a median of $246.5 million in 2024.
  • Per our database at Business Quant, PROCEPT BioRobotics' Equity Average soared by 49729.11% in 2022 and then plummeted by 3311.6% in 2023.
  • PROCEPT BioRobotics' Equity Average (Quarter) stood at $275.2 million in 2021, then decreased by 24.09% to $208.9 million in 2022, then soared by 38.84% to $290.1 million in 2023, then grew by 10.92% to $321.7 million in 2024, then increased by 19.06% to $383.0 million in 2025.
  • Its Equity Average stands at $383.0 million for Q3 2025, versus $387.5 million for Q2 2025 and $395.7 million for Q1 2025.